Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer
Authors:
Open Access
- 15 June 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (12) , 3591-3596
Abstract
Purpose: Despite improvements in cancer treatment, the prognosis of ovarian cancer remains low and imperfectly predicted by traditional pathologic criteria. Biomarkers that predict prognosis independently of such criteria shed light on important molecular variations, aiding in the development and targeting of novel therapies. Previous work has shown human leukocyte antigen (HLA) class I antigen expression to be independently predictive of prognosis in colorectal and breast cancer. We investigated the prognostic potential of HLA class I antigen expression by studying a large series of ovarian cancers. Experimental Design: A tissue microarray of 339 ovarian cancer cases linked to prospectively recorded clinicopathologic and follow-up data was constructed. This was stained following a standard immunohistochemical protocol for HLA class I heavy chain (HC-10) and β2-microglobulin (β2-m). HLA class I antigen expression was compared with clinicopathologic factors and overall disease-specific survival using the Pearson χ2 test, Kaplan-Meier curves, and the log-rank test. Cox regression was used to test for the independence and magnitude of effects. Results: There were no univariate correlations between HLA class I antigen expression and clinicopathologic factors. Deviation from an HC-10+/β2-m+ phenotype correlated with reduced survival in univariate analysis (log-rank, 5.69; P = 0.017); a retained HC-10+/β2-m+ phenotype predicted improved prognosis independently of age, stage, level of cytoreduction, and chemotherapy usage on multivariate analysis (hazard ratio, 0.587; 95% confidence interval, 0.442-0.781; P < 0.001). Conclusions: HLA class I antigen expression is an independent prognostic marker in ovarian cancer, its loss correlating with a poor prognostic outcome.Keywords
This publication has 31 references indexed in Scilit:
- The Coincidence of Chromosome 15 Aberrations and β2-Microglobulin Gene Mutations Is Causative for the Total Loss of Human Leukocyte Antigen Class I Expression in MelanomaClinical Cancer Research, 2006
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.Journal of Clinical Investigation, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomasCurrent Biology, 1996
- Effects of interferon ? on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell linesJournal of Cancer Research and Clinical Oncology, 1993
- Class I histocompatibility antigen expression: A prognostic factor for aneuploid ovarian cancersGynecologic Oncology, 1990
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990
- Evolution of tumours and the impact of molecular oncologyNature, 1985